Alexandra Flemming

Alexandra Flemming is a German biologist, academic, and the editor in chief of Nature Reviews Immunology. Source: Wikipedia (en)

Series

There is nothing here

Create a new serie

Works

There is nothing here

Create a new work

Articles 82

Date

Title

Authors

2020-02-01

bnAbs for HIV: shepherding towards improbable mutations

Alexandra Flemming
2020-05-06

Tumours use NETs as physical shields

Alexandra Flemming
2020-12-02

Nanobiologic trains innate immunity for anticancer responses

Alexandra Flemming
2017-02-01

Autoimmune diseases: Inhibitor of adaptor protein shows self-antigen selectivity.

Alexandra Flemming
2017-02-17

Antifungals: JNK inhibitors boost antifungal immunity

Alexandra Flemming
2016-07-01

Cancer: Allosteric phosphatase inhibitor puts brake on cancer cells

Alexandra Flemming
2016-08-01

Autoimmune diseases: CAR-T cells take aim at autoimmunity.

Alexandra Flemming
2016-11-01

Anticancer drugs: Breaking up a pro-survival interaction.

Alexandra Flemming
2016-11-01

HIV: Sequential vaccine elicits broadly neutralizing antibodies.

Alexandra Flemming
2016-09-01

Cancer: Tumour-specific ablation of Treg cells induces anticancer response.

Alexandra Flemming
2016-06-01

Cancer: Bivalent mTOR inhibitors - the next generation.

Alexandra Flemming
2016-06-01

Anticancer drugs: RAS mimetic revealed.

Alexandra Flemming
2016-12-01

Cancer: Microtubule-straightening compound widens the therapeutic window.

Alexandra Flemming
2016-01-01

Cancer: Engineered T cells gain access to pancreatic tumours

Alexandra Flemming
2016-02-01

Cancer: Mutant p53 rescued by aggregation inhibitor

Alexandra Flemming
2016-04-01

Autoimmunity: Nanoparticles engineered for antigen-specific immunotherapy

Alexandra Flemming
2016-03-01

Cancer: CARs: new models abound

Alexandra Flemming
2015-02-01

Huntington disease: Banking on ATM.

Alexandra Flemming
2015-01-01

Anticancer drugs: Finding the perfect combination.

Alexandra Flemming
2015-04-01

Cancer: An epigenetic target for synthetic lethality.

Alexandra Flemming
2015-07-24

Malaria: Hitting all stages of the parasite life cycle

Alexandra Flemming
2015-10-01

Cancer: Small-molecule FGF trap shrinks tumours

Alexandra Flemming
2015-11-01

Cancer: Antitumour responses with more BiTE

Alexandra Flemming
2015-03-01

Cancer stem cells: Targeting the root of cancer relapse

Alexandra Flemming
2015-04-24

Cancer: Multifunctional nanodevice reverses drug resistance

Alexandra Flemming
2014-06-20

Alzheimer's disease: Aβ-fibrinogen interaction inhibitor improves cognition in AD.

Alexandra Flemming
2014-05-23

Mitochondrial disease: gene therapy protects heart in Friedreich's ataxia

Alexandra Flemming
2014-01-01

Malaria: A step closer to elimination?

Alexandra Flemming
2014-08-22

Epilepsy: endocannabinoid metabolism offers handle to dampen down excitability.

Alexandra Flemming
2014-08-01

Deal watch: Pfizer and GSK join race for T cell cancer therapies.

Alexandra Flemming
2014-03-01

Antibody engineering: fine-tuning antibody-drug conjugates.

Alexandra Flemming
2014-10-01

Cancer: Lipid kinase PIP5K1α as a new target in prostate cancer.

Alexandra Flemming

Human - wd:Q111383279

Welcome to Inventaire

the library of your friends and communities

learn more